[Clozapine and myocarditis]

Area of Science:

• Pharmacology
• Cardiology
• Toxicology

Background:

• Adverse drug reactions pose significant risks, with myocarditis being a severe cardiac complication.
• Clozapine, an antipsychotic medication, has been associated with myocarditis since its market introduction.
• Myocarditis can be fatal and is sometimes discovered incidentally during patient care.

Observation:

• This report focuses on a patient who experienced sudden death following an escalation of clozapine dosage.
• The patient exhibited myocardial findings suggestive of an adverse reaction.
• Pulmonary artery embolism was identified as the immediate cause of death.

Findings:

• Histopathological examination revealed myocardial changes potentially linked to clozapine exposure.
• An allergic adverse reaction to clozapine is hypothesized as the underlying cause of the observed myocarditis.
• The central pulmonary artery embolus was the direct cause of the fatal event.

Implications:

• This case underscores the critical need for monitoring cardiac function in patients treated with clozapine.
• Early recognition and management of clozapine-induced myocarditis are crucial for patient survival.
• Further research into the mechanisms of clozapine-related cardiotoxicity is warranted to improve patient safety.